Cargando…
Publisher Correction: Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652262/ https://www.ncbi.nlm.nih.gov/pubmed/36342618 http://dx.doi.org/10.1007/s40265-022-01805-0 |
| _version_ | 1784828430213185536 |
|---|---|
| author | Khanna, Sahil Assi, Maha Lee, Christine Yoho, David Louie, Thomas Knapple, Whitfield Aguilar, Humberto Garcia-Diaz, Julia Wang, Gary P. Berry, Scott M. Marion, Joe Su, Xin Braun, Tricia Bancke, Lindy Feuerstadt, Paul |
| author_facet | Khanna, Sahil Assi, Maha Lee, Christine Yoho, David Louie, Thomas Knapple, Whitfield Aguilar, Humberto Garcia-Diaz, Julia Wang, Gary P. Berry, Scott M. Marion, Joe Su, Xin Braun, Tricia Bancke, Lindy Feuerstadt, Paul |
| author_sort | Khanna, Sahil |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9652262 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96522622022-11-15 Publisher Correction: Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection Khanna, Sahil Assi, Maha Lee, Christine Yoho, David Louie, Thomas Knapple, Whitfield Aguilar, Humberto Garcia-Diaz, Julia Wang, Gary P. Berry, Scott M. Marion, Joe Su, Xin Braun, Tricia Bancke, Lindy Feuerstadt, Paul Drugs Correction Springer International Publishing 2022-11-07 2022 /pmc/articles/PMC9652262/ /pubmed/36342618 http://dx.doi.org/10.1007/s40265-022-01805-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Correction Khanna, Sahil Assi, Maha Lee, Christine Yoho, David Louie, Thomas Knapple, Whitfield Aguilar, Humberto Garcia-Diaz, Julia Wang, Gary P. Berry, Scott M. Marion, Joe Su, Xin Braun, Tricia Bancke, Lindy Feuerstadt, Paul Publisher Correction: Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection |
| title | Publisher Correction: Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection |
| title_full | Publisher Correction: Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection |
| title_fullStr | Publisher Correction: Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection |
| title_full_unstemmed | Publisher Correction: Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection |
| title_short | Publisher Correction: Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection |
| title_sort | publisher correction: efficacy and safety of rbx2660 in punch cd3, a phase iii, randomized, double-blind, placebo-controlled trial with a bayesian primary analysis for the prevention of recurrent clostridioides difficile infection |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652262/ https://www.ncbi.nlm.nih.gov/pubmed/36342618 http://dx.doi.org/10.1007/s40265-022-01805-0 |
| work_keys_str_mv | AT khannasahil publishercorrectionefficacyandsafetyofrbx2660inpunchcd3aphaseiiirandomizeddoubleblindplacebocontrolledtrialwithabayesianprimaryanalysisforthepreventionofrecurrentclostridioidesdifficileinfection AT assimaha publishercorrectionefficacyandsafetyofrbx2660inpunchcd3aphaseiiirandomizeddoubleblindplacebocontrolledtrialwithabayesianprimaryanalysisforthepreventionofrecurrentclostridioidesdifficileinfection AT leechristine publishercorrectionefficacyandsafetyofrbx2660inpunchcd3aphaseiiirandomizeddoubleblindplacebocontrolledtrialwithabayesianprimaryanalysisforthepreventionofrecurrentclostridioidesdifficileinfection AT yohodavid publishercorrectionefficacyandsafetyofrbx2660inpunchcd3aphaseiiirandomizeddoubleblindplacebocontrolledtrialwithabayesianprimaryanalysisforthepreventionofrecurrentclostridioidesdifficileinfection AT louiethomas publishercorrectionefficacyandsafetyofrbx2660inpunchcd3aphaseiiirandomizeddoubleblindplacebocontrolledtrialwithabayesianprimaryanalysisforthepreventionofrecurrentclostridioidesdifficileinfection AT knapplewhitfield publishercorrectionefficacyandsafetyofrbx2660inpunchcd3aphaseiiirandomizeddoubleblindplacebocontrolledtrialwithabayesianprimaryanalysisforthepreventionofrecurrentclostridioidesdifficileinfection AT aguilarhumberto publishercorrectionefficacyandsafetyofrbx2660inpunchcd3aphaseiiirandomizeddoubleblindplacebocontrolledtrialwithabayesianprimaryanalysisforthepreventionofrecurrentclostridioidesdifficileinfection AT garciadiazjulia publishercorrectionefficacyandsafetyofrbx2660inpunchcd3aphaseiiirandomizeddoubleblindplacebocontrolledtrialwithabayesianprimaryanalysisforthepreventionofrecurrentclostridioidesdifficileinfection AT wanggaryp publishercorrectionefficacyandsafetyofrbx2660inpunchcd3aphaseiiirandomizeddoubleblindplacebocontrolledtrialwithabayesianprimaryanalysisforthepreventionofrecurrentclostridioidesdifficileinfection AT berryscottm publishercorrectionefficacyandsafetyofrbx2660inpunchcd3aphaseiiirandomizeddoubleblindplacebocontrolledtrialwithabayesianprimaryanalysisforthepreventionofrecurrentclostridioidesdifficileinfection AT marionjoe publishercorrectionefficacyandsafetyofrbx2660inpunchcd3aphaseiiirandomizeddoubleblindplacebocontrolledtrialwithabayesianprimaryanalysisforthepreventionofrecurrentclostridioidesdifficileinfection AT suxin publishercorrectionefficacyandsafetyofrbx2660inpunchcd3aphaseiiirandomizeddoubleblindplacebocontrolledtrialwithabayesianprimaryanalysisforthepreventionofrecurrentclostridioidesdifficileinfection AT brauntricia publishercorrectionefficacyandsafetyofrbx2660inpunchcd3aphaseiiirandomizeddoubleblindplacebocontrolledtrialwithabayesianprimaryanalysisforthepreventionofrecurrentclostridioidesdifficileinfection AT banckelindy publishercorrectionefficacyandsafetyofrbx2660inpunchcd3aphaseiiirandomizeddoubleblindplacebocontrolledtrialwithabayesianprimaryanalysisforthepreventionofrecurrentclostridioidesdifficileinfection AT feuerstadtpaul publishercorrectionefficacyandsafetyofrbx2660inpunchcd3aphaseiiirandomizeddoubleblindplacebocontrolledtrialwithabayesianprimaryanalysisforthepreventionofrecurrentclostridioidesdifficileinfection |